Physician profile
Thomas A Page
NPI 1326021544
$298.10
in general payments reported to CMS, 2019-2025
11 companies · $14.82 in 2025
The $14.82 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.04 · 2020: $123 · 2021: $12.12 · 2022: $24.95 · 2023: $15.86 · 2024: $31.75 · 2025: $14.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $56.90 | 2020 | |
| Abbvie INC. | $52.93 | 2021-2023 | |
| Amgen INC. | $36.38 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $29.50 | 2019-2024 | Airsupra |
| Pfizer INC. | $24.93 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $23.69 | 2019 | |
| Ironwood Pharmaceuticals, INC | $16.37 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.46 | 2019 | |
| Exact Sciences Corporation | $14.82 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $14.21 | 2024 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $12.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.